Metabolic components and recurrence in early-stage cervical cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ahn, Hee Kyung | - |
dc.contributor.author | Shin, Jin Woo | - |
dc.contributor.author | Ahn, Hong Yup | - |
dc.contributor.author | Park, Chan-Yong | - |
dc.contributor.author | Lee, Nak Woo | - |
dc.contributor.author | Lee, Jae Kwan | - |
dc.contributor.author | Hwang, In Cheol | - |
dc.date.accessioned | 2021-09-04T18:29:35Z | - |
dc.date.available | 2021-09-04T18:29:35Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2015-03 | - |
dc.identifier.issn | 1010-4283 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/94185 | - |
dc.description.abstract | Epidemiological evidence suggests that the metabolic syndrome (MetS) is associated with increased risk of cervical cancer. However, research on the impact of MetS on prognosis in cervical cancer is lacking. This study investigated the association between MetS and recurrence-free survival (RFS) in patients with early-stage cervical cancer. This is a retrospective study of patients diagnosed with the International Federation of Gynecology and Obstetrics (FIGO) stage I-II cervical cancer in three tertiary hospitals during 2006-2009. Cox proportional hazards model was used to estimate the association between MetS or MetS components and RFS. We were able to evaluate MetS status in 84 patients out of 127. Forty patients had MetS. RFS was not significantly different according to MetS status; however, there was no further event of recurrence in non-MetS group after 2 years from primary surgical treatment. Hypertriglyceridemia (HR 3.67, 95 % CI 1.18-11.43) and impaired fasting glucose (HR 4.30, 95 % CI 1.23-15.03) were independent risk factors for shorter RFS, after adjustment for age, lymph node involvement, tumor involvement of resection margin, parametrial invasion, FIGO stage at diagnosis, and adjuvant treatment. Hypertriglyceridemia and impaired fasting glucose were associated with higher risk of recurrence in patients with early-stage cervical cancer. Prospective validation in large populations and further studies on the impact of MetS treatment in patients with cervical cancer are warranted. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | SAGE PUBLICATIONS LTD | - |
dc.subject | RISK-FACTORS | - |
dc.subject | CARDIOVASCULAR-DISEASE | - |
dc.subject | PHYSICAL-ACTIVITY | - |
dc.subject | BLOOD-GLUCOSE | - |
dc.subject | COHORT | - |
dc.subject | MORTALITY | - |
dc.subject | POPULATION | - |
dc.subject | INSULIN | - |
dc.subject | OBESITY | - |
dc.subject | BREAST | - |
dc.title | Metabolic components and recurrence in early-stage cervical cancer | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Nak Woo | - |
dc.contributor.affiliatedAuthor | Lee, Jae Kwan | - |
dc.identifier.doi | 10.1007/s13277-014-2831-y | - |
dc.identifier.scopusid | 2-s2.0-84930913485 | - |
dc.identifier.wosid | 000351884000098 | - |
dc.identifier.bibliographicCitation | TUMOR BIOLOGY, v.36, no.3, pp.2201 - 2207 | - |
dc.relation.isPartOf | TUMOR BIOLOGY | - |
dc.citation.title | TUMOR BIOLOGY | - |
dc.citation.volume | 36 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 2201 | - |
dc.citation.endPage | 2207 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | RISK-FACTORS | - |
dc.subject.keywordPlus | CARDIOVASCULAR-DISEASE | - |
dc.subject.keywordPlus | PHYSICAL-ACTIVITY | - |
dc.subject.keywordPlus | BLOOD-GLUCOSE | - |
dc.subject.keywordPlus | COHORT | - |
dc.subject.keywordPlus | MORTALITY | - |
dc.subject.keywordPlus | POPULATION | - |
dc.subject.keywordPlus | INSULIN | - |
dc.subject.keywordPlus | OBESITY | - |
dc.subject.keywordPlus | BREAST | - |
dc.subject.keywordAuthor | Uterine cervical neoplasms | - |
dc.subject.keywordAuthor | Metabolic syndrome X | - |
dc.subject.keywordAuthor | Hypertriglyceridemia | - |
dc.subject.keywordAuthor | Obesity | - |
dc.subject.keywordAuthor | Hyperglycemia | - |
dc.subject.keywordAuthor | Prognosis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.